{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:40:28Z","timestamp":1783690828181,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T00:00:00Z","timestamp":1528502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13643-018-0745-2","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T11:39:40Z","timestamp":1528544380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol"],"prefix":"10.1186","volume":"7","author":[{"given":"Joshua","family":"Blair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip I.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7849-0087","authenticated-orcid":false,"given":"Alastair K.","family":"Denniston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,9]]},"reference":[{"issue":"9","key":"745_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/bjo.80.9.844","volume":"80","author":"MS Suttorp-Schulten","year":"1996","unstructured":"Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80(9):844\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"745_CR2","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.4049\/jimmunol.173.8.5290","volume":"173","author":"SJ Curnow","year":"2004","unstructured":"Curnow SJ, Scheel-Toellner D, Jenkinson W, Raza K, Durrani OM, Faint JM, et al. Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6\/soluble IL-6 receptor trans-signalling. J Immunol. 2004;173(8):5290\u20137.","journal-title":"J Immunol"},{"key":"745_CR3","volume-title":"Uveitis","author":"S Lightman","year":"1998","unstructured":"Lightman S, Towler H. Uveitis. 1st ed. United Kingdom: BMJ Publishing Group; 1998. ISBN: 9780727912022","edition":"1"},{"issue":"3","key":"745_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"745_CR5","first-page":"1891","volume":"8","author":"RJ Barry","year":"2014","unstructured":"Barry RJ, Nguyen QD, Lee RW, Murray PI, Denniston AK. Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol. 2014;8:1891\u2013911.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"745_CR6","first-page":"113","volume":"2","author":"M Mikhail","year":"2013","unstructured":"Mikhail M, Sallam A. Novel intraocular therapy in non-infectious uveitis of the posterior segment of the eye. Med Hypothesis Discov Innov Ophthalmol. 2013;2(4):113\u201320.","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"6","key":"745_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00063030-200013060-00003","volume":"13","author":"J Salzmann","year":"2000","unstructured":"Salzmann J, Lightman S. The potential of newer immunomodulating drugs in the treatment of uveitis: a review. BioDrugs. 2000;13(6):397\u2013408.","journal-title":"BioDrugs"},{"issue":"4","key":"745_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492\u2013513.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"745_CR9","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/ijms13021886","volume":"13","author":"H P\u00f3pulo","year":"2012","unstructured":"P\u00f3pulo H, Lopes JM, Soares P. The mTOR signalling pathway in human cancer. Int J Mol Sci. 2012;13(2):1886\u2013918.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"745_CR10","doi-asserted-by":"publisher","first-page":"e0154564","DOI":"10.1371\/journal.pone.0154564","volume":"11","author":"S Hu","year":"2016","unstructured":"Hu S, Chen M, Wang Y, Wang Z, Pei Y, Fan R, et al. mTOR inhibition attenuates dextran sulfate sodium-induced colitis by suppressing T cell proliferation and balancing TH1\/TH17\/Treg profile. PLoS One. 2016;11(4):e0154564.","journal-title":"PLoS One"},{"key":"745_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000438951","volume":"55","author":"A Agarwal","year":"2016","unstructured":"Agarwal A, Rajagopalan N, Hassan M, Sadiq MA, Soliman MK, Afridi R, et al. Sirolimus for retinal and uveitic diseases. Dev Ophthalmol. 2016;55:276\u201381.","journal-title":"Dev Ophthalmol"},{"key":"745_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13023-015-0318-6","volume":"10","author":"AK Denniston","year":"2015","unstructured":"Denniston AK, Holland GN, Kidess A, Nussenblatt RB, Okada AA, Rosenbaum JT, Dick AD. Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis. Orphanet J Rare Dis. 2015;10:97.","journal-title":"Orphanet J Rare Dis"},{"issue":"32","key":"745_CR13","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.2174\/1381612821666150909094907","volume":"21","author":"RJ Barry","year":"2015","unstructured":"Barry RJ, Denniston AK. Controversies in the pharmacological treatment of uveitis. Curr Pharm Des. 2015;21(32):4682\u20137.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"745_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Int J Surg. 2010;8(5):336\u201341.","journal-title":"Int J Surg"},{"key":"745_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184","volume-title":"Cochrane handbook for systematic reviews of interventions: Cochrane book series: Wiley Blackwell: Chichester, England, Hoboken, NJ","author":"JP Higgins","year":"2008","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions: Cochrane book series: Wiley Blackwell: Chichester, England, Hoboken, NJ; 2008."},{"key":"745_CR16","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JAC Sterne","year":"2016","unstructured":"Sterne JAC, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"745_CR17","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2000 [20\/10\/2015]. Available from: \n                    http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n                    \n                  ."},{"key":"745_CR18","volume-title":"Undertaking systematic reviews of research on effectiveness: CRD\u2019s guidance for those carrying out or commissioning reviews (2nd Edition). CRD Report 4","author":"Centre for Reviews and Dissemination","year":"2001","unstructured":"Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness: CRD\u2019s guidance for those carrying out or commissioning reviews (2nd Edition). CRD Report 4. York: University of York; 2001."},{"key":"745_CR19","first-page":"311","volume":"107","author":"PK Kaiser","year":"2009","unstructured":"Kaiser PK. Prospective evaluation of visual acuity assessment: a comparison of Snellen versus ETDRS charts in clinical practice (an AOS thesis). Trans Am Ophthalmol Soc. 2009;107:311\u201324.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"745_CR20","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"10","key":"745_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","volume":"61","author":"JL Peters","year":"2008","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61(10):991\u20136.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"745_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jval.2011.04.002","volume":"14","author":"JP Jansen","year":"2011","unstructured":"Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR task force on indirect treatment comparisons good research practices: part 1. Value Health. 2011;14(4):417\u201328.","journal-title":"Value Health"},{"issue":"7700","key":"745_CR23","first-page":"932","volume":"338","author":"F Song","year":"2009","unstructured":"Song F, Loke YK, Walsh T, Glenny A-M, Eastwood AJ, Altman DG. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ. 2009;338(7700):932\u20135.","journal-title":"BMJ"},{"key":"745_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2415-13-18","volume":"13","author":"AK Denniston","year":"2013","unstructured":"Denniston AK, Dick AD. Systemic therapies for inflammatory eye disease: past, present and future. BMC Ophthalmol. 2013;13:18.","journal-title":"BMC Ophthalmol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0745-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-018-0745-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0745-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T19:05:29Z","timestamp":1560020729000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-018-0745-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1186\/s13643-018-0745-2","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,9]]},"assertion":[{"value":"12 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"83"}}